Business / Finance

RSS

PlasmaTech Biopharmaceuticals inks agreement to commercialize MuGard in Australia, New Zealand

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing patient care in critical areas, has entered into an exclusive license agreement with Norgine B.V., a European specialist pharmaceutical company, for the commercialization of MuGard in Australia and New Zealand.

27 Oct 2014

Cadens Medical Imaging partners with Hisense Medical to launch 2D/3D Univiewer in China

Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.

27 Oct 2014

Vanda reports total revenues of $14.8 million for third quarter 2014

Vanda Pharmaceuticals Inc., today announced financial and operational results for the third quarter ended September 30, 2014.

27 Oct 2014

MinuteClinic enters into clinical collaboration agreement with Lifespan

MinuteClinic, the retail medical clinic of CVS Health, and Lifespan, Rhode Island's largest health system, which includes five partner hospitals and multiple physician groups, announced today that they have entered into a clinical collaboration agreement.

27 Oct 2014

Roper Industries' GAAP revenue increases 7% to $884 million in Q3 2014

Roper Industries, Inc. reported financial results for the third quarter ended September 30, 2014.

27 Oct 2014

CTI BioPharma acquires worldwide rights to tosedostat

CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America.

27 Oct 2014

MPI Research announces acquisition of Jasper Clinical Research & Development

MPI Research today announced it has acquired the assets of Kalamazoo, Mich.-based Jasper Clinical Research & Development, Inc. Jasper is a respected clinical research organization that provides early-stage human clinical testing of promising new drugs, and is well known to pharmaceutical and biotechnology companies worldwide.

27 Oct 2014

Vancive and Aspen Medical partner to distribute absorbent wound dressing products in the UK, Ireland

Vancive Medical Technologies and Aspen Medical Europe Ltd. today announced an agreement for the exclusive distribution of the Vancive BeneHold Absorbent Wound Dressing portfolio in the United Kingdom and Ireland.

25 Oct 2014

Oncolytics signs equity distribution agreement with Canaccord Genuity

Oncolytics Biotech Inc. announced today that it has entered into an "at-the-market" (ATM) equity distribution agreement with Canaccord Genuity Inc. acting as sole agent.

25 Oct 2014

Aseptika selected for Discovery Start-Ups 2014 award

Aseptika Limited was selected as one of five winners out of the eighteen strong field of UK start-up companies pitching for the winning prizes at the Discovery Start-Ups 2014 event held on Wednesday, 22nd October at Deloitte’s in London.

24 Oct 2014

The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

Hokkaido University and Hitachi, Ltd. have announced that the approval under Japan’s Pharmaceutical Affairs Law has been granted to Hitachi for the manufacture and sales of the PROBEAT-RT, a proton beam therapy treatment system combining spot scanning irradiation and Real-time Tumor-tracking Radiation Therapy.

23 Oct 2014

Global hospital sector investing in new equipment to drive efficiency gains & profitability, GE Capital research finds

Hospitals across the globe are becoming increasingly confident about their growth prospects for the year ahead despite rising costs and ongoing economic uncertainty, according to GE Capital’s inaugural Hospital Sentiment Research – a report based on interviews with more than 380 senior hospital executives with responsibility for budget decisions over eight international markets.

23 Oct 2014

Telstra launches vision for a more connected healthcare system

Today Telstra officially launched a new business division, Telstra Health, and outlined its ambition to become Australia’s leading provider of integrated eHealth solutions.

21 Oct 2014

Crown Bioscience announces U.S. expansion with new translational oncology center

Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced the opening of the Crown Bioscience US Research Center to be located at the David H. Murdock Research Institute (DHMRI), in Kannapolis, N.C. The new center, which will open in the 3rd quarter of 2014, represents significant U.S. market expansion for Crown.

21 Oct 2014

YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist -- PAS-YNSα8 -- which has been jointly developed by scientists at the Weizmann Institute and XL-protein.

21 Oct 2014

Marken to expand global cold chain network to meet demand for packaging solutions

Marken confirmed today that their global cold chain network will be expanded to respond to the growing need for just in time conditioning and preparation of temperature controlled packaging solutions.

21 Oct 2014

SensorUp, Vivametrica partner to standardize wearable device data for healthcare environments

The exponential growth in the number of people tracking their health through activity monitors and biosensor devices is driving the need for industry standards.

21 Oct 2014

Directed Genomics, New England Biolabs to develop new technologies for NGS

New England Biolabs (NEB®) and Directed Genomics together announce that they have established a partnership to develop a suite of new technologies for next generation sequencing (NGS), including target enrichment.

From New England Biolabs 20 Oct 2014

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

Indianapolis interventional medical device maker NICO Corporation and Toronto-based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery.

20 Oct 2014

AmeriCann announces $9M alliance with medical marijuana applicants in Illinois

AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.

20 Oct 2014

Business / Finance

PlasmaTech Biopharmaceuticals inks agreement to commercialize MuGard in Australia, New Zealand

Cadens Medical Imaging partners with Hisense Medical to launch 2D/3D Univiewer in China

Vanda reports total revenues of $14.8 million for third quarter 2014

MinuteClinic enters into clinical collaboration agreement with Lifespan

Roper Industries' GAAP revenue increases 7% to $884 million in Q3 2014

CTI BioPharma acquires worldwide rights to tosedostat

MPI Research announces acquisition of Jasper Clinical Research & Development

Vancive and Aspen Medical partner to distribute absorbent wound dressing products in the UK, Ireland

Oncolytics signs equity distribution agreement with Canaccord Genuity

Aseptika selected for Discovery Start-Ups 2014 award

The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

Global hospital sector investing in new equipment to drive efficiency gains & profitability, GE Capital research finds

Telstra launches vision for a more connected healthcare system

Crown Bioscience announces U.S. expansion with new translational oncology center

YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

Marken to expand global cold chain network to meet demand for packaging solutions

SensorUp, Vivametrica partner to standardize wearable device data for healthcare environments

Directed Genomics, New England Biolabs to develop new technologies for NGS

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

AmeriCann announces $9M alliance with medical marijuana applicants in Illinois

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News